2024. Measurable Residual Disease Monitoring by Multiparameter Flow Cytometry and Relapse Prediction in Adult Acute Myeloid Leukemia. Annals of Leukemia Research. 5, 1 (Aug. 2024), 1–6. DOI:https://doi.org/10.5281/zenodo.22227540.